Q61 什么是乙型肝炎恢复期？
乙型肝炎恢复期是指既往有急性乙型肝炎或CHB病史，HBsAg转阴，抗-HBs阳性或阴性，抗-HBc阳性，HBV DNA低于检测下限，ALT在正常范围。然而，有研究显示，HBsAg消失后，仍有部分患者的肝脏中可检测出HBV共价闭合环状DNA（cccDNA），当机体处于免疫抑制状态时，可能出现HBV再激活和乙型肝炎复发。
（喻一奇 张文宏）
参考文献
[1] Lai C L, Ratziu V, Yuen M F, et al. Viral hepatitis B[J]. Lancet, 2003, 362(9401): 2089-2094.
[2] 王贵强, 王福生, 成军, 等. 慢性乙型肝炎防治指南 (2015更新版) [J]. 中华肝脏病杂志, 2015, 21(12): 219-240.
[3] Sarin S K, Kumar M, Lau G K, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update[J]. Hepatology International, 2016, 10(1): 1.
[4] Mcmahon B J, Hoofnagle J H, Doo E. The natural history of chronic hepatitis B virus infection[J]. Seminars in Liver Disease, 2004, 24 Suppl 1(Supplement S5): 17.
[5] Yunfan L. Natural history of chronic hepatitis B virus infection and long-term outcome under treatment[J]. Liver International Official Journal of the International Association for the Study of the Liver, 2009, 29 Suppl 1(s1): 100.
[6] Liaw Y F. Hepatitis flares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy[J]. Journal of Gastroenterology & Hepatology, 2003, 18(3): 246–252.
[7] Chu C M, Hung S J, Lin J, et al. Natural history of hepatitis B e antigen to antibody seroconversion in patients with normal serum aminotransferase levels[J]. American Journal of Medicine, 2004, 116(12): 829.(https://www.daowen.com)
[8] Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors[J]. Journal of Hepatology, 2008, 48(2): 335-352.
[9] Mcmahon B J, Holck P, Bulkow L, et al. Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus[J]. Annals of Internal Medicine, 2001, 135(9): 759-768.
[10] Fattovich G. Natural history and prognosis of hepatitis B[J]. Seminars in Liver Disease, 2003, 23(1): 47-58.
[11] Tseng T C, Liu C J, Yang H C, et al. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load[J]. Gastroenterology, 2012, 142(5): 1140-1149.
[12] Farci P, Alter H J, Wong D, et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis[J]. N Engl J Med, 1991, 325(2): 98-104.
[13] Corey K E, Mendeznavarro J, Gorospe E C, et al. Early treatment improves outcomes in acute hepatitis C virus infection: a meta-analysis[J]. Journal of Viral Hepatitis, 2010, 17(3): 201-207.
[14] 中华医学会肝病学分会. 丙型肝炎防治指南(2015更新版)[J]. 肝脏, 2015, 23(12): 933-949.
[15] Elserag H B, Rudolph K L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis[J]. Gastroenterology, 2007, 132(7): 2557-2576.
[16] Huang Y W, Yang S S, Fu S C, et al. Increased risk of cirrhosis and its decompensation in chronic hepatitis C patients with new-onset diabetes: a nationwide cohort study[J]. Hepatology, 2014, 60(3): 807-814.